Skip to main content

Table 3 Comparison of characteristics and VAS levels at entry recorded during and outside the pollen season

From: Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

   During pollen season (n = 6939) Outside pollen season (n = 2098) P value
Symptoms Day 1
  Itchy nose (%) 73 66 <0.001
  Sneezing (%) 61 55 <0.001
  Congestion (%) 69 65 0.001
  Red eyes (%) 46 37 <0.001
  Itchy eyes (%) 68 53 <0.001
  Watery eyes (%) 47 38 <0.001
Impact of symptoms Day 1
  Sleep (%) 38 35 0.06
  Daily activities (%) 45 39 <0.001
  Work/school (%) 30 26 <0.001
  Bothersome (%) 76 68 <0.001
ARIA score (%) 0 14 20  
  1 30 32  
  2 25 21 <0.001
  3 18 16  
  4 14 12  
  Median [p25-p75] 2 [1–3] 1 [1–3] <0.001
  1. FF Fluticasone Furoate, FP Fluticasone Propionate, MF Mometasone Furoate, MPAzeFlu Azelastine-Fluticasone Propionate
  2. *Chi square tests were used for categorical variables (i.e. baseline symptoms and impact of symptoms, ARIA score); Kruskal–Wallis tests were used for continuous variables (i.e. ARIA score)
  3. p25: 25th percentile; p75: 75th percentile
\